---
title: "Metolazone - Hypertensive Disorder - 2"
sidebar: mydoc_sidebar
permalink: db00524-mesh-d006973-2.html
toc: false 
---


Path ID: `DB00524_MESH_D006973_2`
{% include image.html url="images/db00524-mesh-d006973-2.png" file="db00524-mesh-d006973-2.png" alt="db00524-mesh-d006973-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D008788 | Metolazone | Drug |
| UniProt:P55017 | Solute carrier family 12 member 3 | Protein |
| GO:0070294 | Renal sodium ion absorption | BiologicalProcess |
| GO:0003092 | Renal water retention | BiologicalProcess |
| HP:0011104 | Abnormality of blood volume homeostasis | PhenotypicFeature |
| GO:0045777 | Up regulation of blood pressure | BiologicalProcess |
| MESH:D006973 | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Metolazone | DECREASES ACTIVITY OF | Solute Carrier Family 12 Member 3 |
| Solute Carrier Family 12 Member 3 | PARTICIPATES IN | Renal Sodium Ion Absorption |
| Renal Sodium Ion Absorption | POSITIVELY CORRELATED WITH | Renal Water Retention |
| Renal Water Retention | CONTRIBUTES TO | Abnormality Of Blood Volume Homeostasis |
| Abnormality Of Blood Volume Homeostasis | CONTRIBUTES TO | Up Regulation Of Blood Pressure |
| Up Regulation Of Blood Pressure | AFFECTS RISK FOR | Hypertensive Disorder |
|---------|-----------|---------|

Comment: The antihypertensive mechanism of bendroflumethiazide is not well understood.

Reference: 
  - [https://go.drugbank.com/drugs/DB00524](https://go.drugbank.com/drugs/DB00524)
